Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Liu Y;Liu Y; Sinha S; McDonald OG; Shang Y; Hoofnagle MH; Owens GK
- Source:
The Journal of biological chemistry [J Biol Chem] 2005 Mar 11; Vol. 280 (10), pp. 9719-27. Date of Electronic Publication: 2004 Dec 28.
- Publication Type:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
- Language:
English
- Additional Information
- Source:
Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 2985121R Publication Model: Print-Electronic Cited Medium: Print ISSN: 0021-9258 (Print) Linking ISSN: 00219258 NLM ISO Abbreviation: J Biol Chem Subsets: MEDLINE
- Publication Information:
Publication: 2021- : [New York, NY] : Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology
Original Publication: Baltimore, MD : American Society for Biochemistry and Molecular Biology
- Subject Terms:
- Abstract:
Platelet-derived growth factor BB (PDGF-BB) has been shown to be an extremely potent negative regulator of smooth muscle cell (SMC) differentiation. Moreover, previous studies have demonstrated that the Kruppel-like transcription factor (KLF) 4 potently represses the expression of multiple SMC genes. However, the mechanisms whereby KLF4 suppresses SMC gene expression are not known, nor is it clear whether KLF4 contributes to PDGF-BB-induced down-regulation of SMC genes. The goals of the present studies were to determine the molecular mechanisms by which KLF4 represses expression of SMC genes and whether it contributes to PDGF-BB-induced suppression of these genes. Results demonstrated that KLF4 markedly repressed both myocardin-induced activation of SMC genes and expression of myocardin. KLF4 was rapidly up-regulated in PDGF-BB-treated, cultured SMC, and a small interfering RNA to KLF4 partially blocked PDGF-BB-induced SMC gene repression. Both PDGF-BB and KLF4 markedly reduced serum response factor binding to CArG containing regions within intact chromatin. Finally, KLF4, which is normally not expressed in differentiated SMC in vivo, was rapidly up-regulated in vivo in response to vascular injury. Taken together, results indicate that KLF4 represses SMC genes by both down-regulating myocardin expression and preventing serum response factor/myocardin from associating with SMC gene promoters, and suggest that KLF4 may be a key effector of PDGF-BB and injury-induced phenotypic switching of SMC.
- Grant Information:
P01HL19242 United States HL NHLBI NIH HHS; R01HL38854 United States HL NHLBI NIH HHS; R37HL57353 United States HL NHLBI NIH HHS
- Accession Number:
0 (Chromatin)
0 (DNA-Binding Proteins)
0 (Klf4 protein, mouse)
0 (Klf4 protein, rat)
0 (Kruppel-Like Factor 4)
0 (Kruppel-Like Transcription Factors)
0 (Nuclear Proteins)
0 (Platelet-Derived Growth Factor)
0 (Proto-Oncogene Proteins c-sis)
0 (Trans-Activators)
0 (Transcription Factors)
0 (myocardin)
1B56C968OA (Becaplermin)
- Publication Date:
Date Created: 20041230 Date Completed: 20050419 Latest Revision: 20220310
- Publication Date:
20221213
- Accession Number:
10.1074/jbc.M412862200
- Accession Number:
15623517
No Comments.